You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Claims for Patent: 10,188,697


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,188,697
Title:Glycopeptide compositions
Abstract: Solutions comprising a glycopeptide antibiotic, for example Vancomycin, and an amino acid or amino acid derivative such as N-acetyl-Glycine or N-acetyl-D-Alanine are provided. These solutions are stable or stabilized for long-term periods at conditions of normal use and storage, and can be formulated as pharmaceutical solutions for use in subjects. Methods of manufacturing and using these solutions are also provided, as are methods of stabilizing a glycopeptide antibiotic, for example Vancomycin, using amino acids or amino acid derivatives such as N-acetyl-Glycine or N-acetyl-D-Alanine.
Inventor(s): Jasprica; Ivona (Zagreb, HR), Keser; Sabina (Zagreb, HR), Pindric; Katarina (Sesvete, HR)
Assignee: XELLIA PHARMACEUTICALS APS (Kobenhavn S, DK)
Application Number:15/524,653
Patent Claims: 1. A pharmaceutical composition comprising a glycopeptide antibiotic; an excipient selected from N-acetyl-D-Alanine and N-acetyl-Glycine; and an amino acid.

2. The pharmaceutical composition of claim 1, wherein the pharmaceutical composition is for parenteral administration.

3. The pharmaceutical composition of claim 1, in the form of a liquid pharmaceutical composition.

4. The pharmaceutical composition of claim 3, wherein the liquid pharmaceutical composition is an aqueous pharmaceutical composition.

5. The pharmaceutical composition of claim 1 wherein the amino acid is selected from Glycine, Alanine, Serine, Leucine, Valine, Lysine, Arginine and Ornithine.

6. The pharmaceutical composition of claim 1, wherein the amino acid is selected from D-Alanine, D-Serine, D-Leucine, D-Valine, L-Lysine, D-Lysine, L-Ornithine, D-Ornithine and L-Arginine.

7. The pharmaceutical composition of claim 6, wherein the amino acid is selected from L-Lysine, D-Lysine, L-Ornithine, D-Ornithine and L-Arginine.

8. The pharmaceutical composition of claim 7, wherein the amino acid is selected from L-Lysine and D-Lysine.

9. The pharmaceutical composition of claim 1, having a pH of about 3-6.

10. The pharmaceutical composition of claim 1, wherein the concentration of the glycopeptide antibiotic is 0.1-1% w/V; and wherein N-acetyl-D-Alanine is present in a molar ratio of 1.1-40:1 to the glycopeptide antibiotic.

11. The pharmaceutical composition of claim 1, wherein the concentration of the glycopeptide antibiotic is 1-10% w/V; and wherein N-acetyl-D-Alanine is present in a molar ratio of 1.1-40:1 to the glycopeptide antibiotic.

12. The pharmaceutical composition of claim 1, wherein the glycopeptide antibiotic is Vancomycin, Teicoplanin, Telavancin, Dalbavancin or Oritavancin.

13. The pharmaceutical composition of claim 4, wherein the pharmaceutical composition is stable for at least 4 weeks at 25 degrees Celsius, wherein stability is demonstrated by determining the amount of the glycopeptide antibiotic remaining in the pharmaceutical composition after at least 4 weeks at 25 degrees Celsius wherein the amount of glycopeptide antibiotic remaining in the pharmaceutical solution is between about 85% and 100%.

14. A method for treating bacterial infections in a subject, comprising administering an aqueous pharmaceutical composition comprising a glycopeptide antibiotic, an excipient selected from N-acetyl-D-Alanine and N-acetyl-Glycine, and an amino acid.

15. The method of claim 14, wherein the pharmaceutical composition is administered parenterally.

16. A method for stabilizing a glycopeptide antibiotic in a pharmaceutical solution, comprising mixing N-acetyl-D-Alanine or N-acetyl Glycine, the glycopeptide antibiotic, and an amino acid.

17. The method of claim 16, wherein the N-acetyl-D-Alanine or N-acetyl Glycine is added to a solution comprising the glycopeptide antibiotic, or the glycopeptide antibiotic is added to a solution comprising the N-acetyl-D-Alanine or N-acetyl-Glycine.

18. The method of claim 16, wherein the N-acetyl-D-Alanine is added to a solution comprising the glycopeptide antibiotic, or the glycopeptide antibiotic is added to a solution comprising the N-acetyl-D-Alanine.

19. The method of claim 16, wherein the pharmaceutical solution is for parenteral administration.

20. The method of claim 16, wherein the pharmaceutical solution is stable for at least 4 weeks at 25 degrees Celsius, wherein stability is demonstrated by determining the amount of the glycopeptide antibiotic remaining in the pharmaceutical solution after at least 4 weeks at 25 degrees Celsius, wherein the amount of glycopeptide antibiotic remaining in the pharmaceutical solution is between about 85% and 100%.

21. The pharmaceutical composition of claim 1, wherein the molar ratio of the amino acid to glycopeptide antibiotic is about 0.5:1 to 40:1.

22. The pharmaceutical composition of claim 1, wherein the concentration of the glycopeptide antibiotic is about 0.1-20% w/V.

23. The pharmaceutical composition of claim 1, comprising about 0.5-15% w/V of the glycopeptide antibiotic, wherein the molar ratio of the N-acetyl-D-Alanine to the glycopeptide antibiotic is about 1:1 to 40:1.

24. The pharmaceutical composition of claim 1, comprising about 0.5-15% w/V glycopeptide antibiotic, wherein the molar ratio of the N-acetyl-D-Alanine to the glycopeptide antibiotic is about 1:1 to 40:1.

25. The pharmaceutical composition of claim 1, comprising about 0.5-15% w/V glycopeptide antibiotic, wherein the molar ratio of the N-acetyl-D-Alanine to the glycopeptide antibiotic is about 1:1 to 40:1, wherein the pharmaceutical composition has a pH of about 3-6 and comprises an amino acid selected from Serine, Leucine, Valine, Lysine, Arginine and Ornithine.

26. The method of claim 14, wherein the pharmaceutical composition comprises about 0.5-15% w/V of the glycopeptide antibiotic, wherein the molar ratio of the N-acetyl-D-Alanine to the glycopeptide antibiotic is about 1:1 to 40:1.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.